| Novel CAR T therapy is a ray of hope in the treatment of seriously ill AML patients F Marofi, HS Rahman, ZMJ Al-Obaidi, AT Jalil, WK Abdelbasset, ... Stem Cell Research & Therapy 12, 1-23, 2021 | 183 | 2021 |
| A comprehensive review about immune responses and exhaustion during coronavirus disease (COVID-19) RN Mohammed, R Tamjidifar, HS Rahman, A Adili, S Ghoreishizadeh, ... Cell Communication and Signaling 20 (1), 79, 2022 | 37 | 2022 |
| Tumor necrosis factor‑α in systemic lupus erythematosus: Structure, function and therapeutic implications F Ghorbaninezhad, P Leone, H Alemohammad, B Najafzadeh, ... International Journal of Molecular Medicine 49 (4), 1-13, 2022 | 19 | 2022 |
| Dendritic cell-derived exosomes: a new horizon in personalized cancer immunotherapy? F Ghorbaninezhad, H Alemohammad, B Najafzadeh, J Masoumi, ... Cancer Letters 562, 216168, 2023 | 15 | 2023 |
| miR-200c increases the sensitivity of breast cancer cells to Doxorubicin through downregulating MDR1 gene S Safaei, M Amini, S Najjary, A Mokhtarzadeh, N Bolandi, H Saeedi, ... Experimental and Molecular Pathology 125, 104753, 2022 | 14 | 2022 |
| Cancer combination therapies by silencing of CTLA‐4, PD‐L1, and TIM3 in osteosarcoma AD Sorkhabi, A Sarkesh, A Fotouhi, H Saeedi, L Aghebati‐Maleki IUBMB life 74 (9), 908-917, 2022 | 12 | 2022 |
| The basis and advances in clinical application of cytomegalovirus-specific cytotoxic T cell immunotherapy for glioblastoma multiforme A Daei Sorkhabi, A Sarkesh, H Saeedi, F Marofi, M Ghaebi, N Silvestris, ... Frontiers in Oncology 12, 818447, 2022 | 12 | 2022 |
| Anastasis: cell recovery mechanisms and potential role in cancer RN Mohammed, M Khosravi, HS Rahman, A Adili, N Kamali, ... Cell Communication and Signaling 20 (1), 81, 2022 | 11 | 2022 |
| Survivin; a novel therapeutic target that correlates with survival of autoreactive T lymphocytes obtained from patients with ankylosing spondylitis N Shomali, B Baradaran, AD Sorkhabi, A Sarkesh, MS Kahrizi, F Tosan, ... Gene 844, 146829, 2022 | 8 | 2022 |
| Targeted therapy of B7 family checkpoints as an innovative approach to overcome cancer therapy resistance: a review from chemotherapy to immunotherapy B Amir Taghavi, N Alizadeh, H Saeedi, N Karim Ahangar, A Derakhshani, ... Molecules 27 (11), 3545, 2022 | 6 | 2022 |
| Restoration of miR-124 serves as a promising therapeutic approach in CRC by affecting CDK6 which is itself a prognostic and diagnostic factor M Akbari, A Adili, A Faraji, A Pakdel, R Aslaminabad, D Nasrabadi, ... Gene Reports 24, 101274, 2021 | 4 | 2021 |
| siRNA-Mediated B7H7 Knockdown in Gastric Cancer Lysate-Loaded Dendritic Cells Amplifies Expansion and Cytokine Secretion of Autologous T Cells J Masoumi, F Ghorbaninezhad, H Saeedi, S Safaei, V Khaze Shahgoli, ... Biomedicines 11 (12), 3212, 2023 | 3 | 2023 |
| Immune features of tumor microenvironment: a genetic spotlight M Asadi, H Zarredar, V Zafari, Z Soleimani, H Saeedi, A Caner, ... Cell Biochemistry and Biophysics 82 (1), 107-118, 2024 | 2 | 2024 |
| Current approaches in glioblastoma multiforme immunotherapy M Aghajani, N Jalilzadeh, A Aghebati-Maleki, A Yari, P Tabnak, A Mardi, ... Clinical and Translational Oncology, 1-29, 2024 | 1 | 2024 |
| The Association of Elevated Levels of LDH and CK-MB with Cardiac Injury and Mortality in COVID-19 Patients F Ghorbaninezhad, M Bakhshivand, H Saeedi, N Alizadeh ImmunoAnalysis 2 (1), 8-8, 2022 | 1 | 2022 |
| Boosting T cell numbers to fight COVID-19 RN Mohammad, R Tamjidifar, HS Rahman, A Adili, S Ghoreishizadeh, ... | | 2023 |
| Anastasis: How cancer cells cheat death RN Mohammed, M Khosravi, HS Rahman, A Adili, N Kamali, ... | | 2023 |
| Correction to: Expression of proliferation-related genes in BM-MSC-treated ALL cells in hypoxia condition is regulated under the influence of epigenetic factors in-vitro X Yang, Y Wang, HS Rahman, TAM Mohammad, SE Korsakov, ... Medical Oncology 39 (9), 2022 | | 2022 |
| Expression of proliferation-related genes in BM-MSC-treated ALL cells in hypoxia condition is regulated under the influence of epigenetic factors in-vitro X Yang, Y Wang, HS Rahman, TAM Mohammad, AD Sorkhabi, ... Medical Oncology 39 (7), 88, 2022 | | 2022 |
| Boosting T cell numbers to fight COVID-19 (preprint) RN Mohammad, S Danshina, HS Rahman, A Adili, S Ghoreishizadeh, ... | | 2022 |
behzad baradaranImmunology Research Center, Tabriz University of Medical Sciences在 tbzmed.ac.ir 的电子邮件经过验证
behzad baradaranImmunology Research Center, Tabriz University of Medical Sciences在 tbzmed.ac.ir 的电子邮件经过验证